These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 32271158
21. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma. Xue X, Wang C, Xue Z, Wen J, Han J, Ma X, Zang X, Deng H, Guo R, Asuquo IP, Qin C, Wang H, Gao Q, Liu S, Wang J. Acta Biochim Biophys Sin (Shanghai); 2020 Mar 18; 52(3):281-293. PubMed ID: 32073597 [Abstract] [Full Text] [Related]
22. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis. Zhang L, Li H, Yuan M, Li D, Sun C, Wang G. Dis Markers; 2020 Mar 18; 2020():2456340. PubMed ID: 32076458 [Abstract] [Full Text] [Related]
24. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis. Zhang X, Tan J, Chen Y, Ma S, Bai W, Peng Y, Shi G. BMC Pulm Med; 2022 Dec 16; 22(1):479. PubMed ID: 36522766 [Abstract] [Full Text] [Related]
25. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer. Zheng B, Peng M, Gong J, Li C, Cheng H, Li Y, Tang Y. Exp Biol Med (Maywood); 2023 Aug 16; 248(16):1403-1413. PubMed ID: 37551102 [Abstract] [Full Text] [Related]
26. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation. Yoshizawa S, Umezu T, Saitoh Y, Gotoh M, Akahane D, Kobayashi C, Ohyashiki JH, Ohyashiki K. Int J Mol Sci; 2018 Aug 23; 19(9):. PubMed ID: 30142940 [Abstract] [Full Text] [Related]
27. Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Chen L, Li Y, Lu J. Technol Cancer Res Treat; 2020 Aug 23; 19():1533033820964222. PubMed ID: 33317398 [Abstract] [Full Text] [Related]
28. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Silva J, García V, Zaballos Á, Provencio M, Lombardía L, Almonacid L, García JM, Domínguez G, Peña C, Diaz R, Herrera M, Varela A, Bonilla F. Eur Respir J; 2011 Mar 23; 37(3):617-23. PubMed ID: 20595154 [Abstract] [Full Text] [Related]
29. Potential circulating miRNA signature for early detection of NSCLC. Arab A, Karimipoor M, Irani S, Kiani A, Zeinali S, Tafsiri E, Sheikhy K. Cancer Genet; 2017 Oct 23; 216-217():150-158. PubMed ID: 29025589 [Abstract] [Full Text] [Related]
30. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer. Zhang ZJ, Song XG, Xie L, Wang KY, Tang YY, Yu M, Feng XD, Song XR. Exp Biol Med (Maywood); 2020 Oct 23; 245(16):1428-1436. PubMed ID: 32741216 [Abstract] [Full Text] [Related]
31. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer. Kanaoka R, Iinuma H, Dejima H, Sakai T, Uehara H, Matsutani N, Kawamura M. Oncology; 2018 Oct 23; 94(5):311-323. PubMed ID: 29533963 [Abstract] [Full Text] [Related]
32. [Clinical Application of Plasma miR-34b-3p and miR-302a-5p in the Diagnosis of Non-small Cell Lung Cancer]. Song Z, Zhang Z, Liu Y. Zhongguo Fei Ai Za Zhi; 2019 Apr 20; 22(4):216-222. PubMed ID: 31014439 [Abstract] [Full Text] [Related]
33. Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases. Li H, Xia M, Zheng S, Lin Y, Yu T, Xie Y, Shen Y, Liu X, Qian X, Yin Z. Biotechnol Genet Eng Rev; 2024 Apr 20; 40(1):359-380. PubMed ID: 36852928 [Abstract] [Full Text] [Related]
34. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma. He T, Lu C, Gong W, Ge Z, Li R, Li X, Sun C, Li W, Long Q, Liu Q, Lai Y. Front Biosci (Landmark Ed); 2024 May 13; 29(5):186. PubMed ID: 38812297 [Abstract] [Full Text] [Related]
35. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection. Zhang H, Zou X, Wu L, Zhang S, Wang T, Liu P, Zhu W, Zhu J. Cancer Med; 2020 Feb 13; 9(3):1230-1241. PubMed ID: 31856390 [Abstract] [Full Text] [Related]
36. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer. Tang Y, Zhao Y, Song X, Song X, Niu L, Xie L. J Clin Lab Anal; 2019 Nov 13; 33(9):e23004. PubMed ID: 31420913 [Abstract] [Full Text] [Related]
37. Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer. Liu J, Yoo J, Ho JY, Jung Y, Lee S, Hur SY, Choi YJ. J Ovarian Res; 2021 Apr 28; 14(1):59. PubMed ID: 33910598 [Abstract] [Full Text] [Related]
38. Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer. Dinh TK, Fendler W, Chałubińska-Fendler J, Acharya SS, O'Leary C, Deraska PV, D'Andrea AD, Chowdhury D, Kozono D. Radiat Oncol; 2016 Apr 27; 11():61. PubMed ID: 27117590 [Abstract] [Full Text] [Related]
39. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing. Dai D, Tan Y, Guo L, Tang A, Zhao Y. Eur J Endocrinol; 2020 Jan 27; 182(1):111-121. PubMed ID: 31721725 [Abstract] [Full Text] [Related]